Spots Global Cancer Trial Database for CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
Official Title: CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
Study ID: NCT04691713
Study Description
Brief Summary: This study is a clinical study of CD276 CAR-T in the treatment of patients with advanced solid tumors. The purpose is to evaluate the safety and effectiveness of targeting CD276 auto-chimeric antigen receptor T cells in the treatment of CD276-positive advanced solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 3 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Bin Hu Hospital, Hefei, Anhui, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
